Lammie
2021-06-24
[Smile]
Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval<blockquote>礼来公司(Eli Lilly)股价上涨，百健(Biogen)因阿尔茨海默病治疗获得批准而下跌</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":126011346,"tweetId":"126011346","gmtCreate":1624537117185,"gmtModify":1634004742954,"author":{"id":3579863048316157,"idStr":"3579863048316157","authorId":3579863048316157,"authorIdStr":"3579863048316157","name":"Lammie","avatar":"https://static.tigerbbs.com/22f853e264a96287b9819a7a9d2d2f84","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><span>[Smile] </span><br></p></body></html>","htmlText":"<html><head></head><body><p><span>[Smile] </span><br></p></body></html>","text":"[Smile]","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/126011346","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=zh_CN&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval<blockquote>礼来公司(Eli Lilly)股价上涨，百健(Biogen)因阿尔茨海默病治疗获得批准而下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p><p><blockquote><i><b>（更新：美国东部时间2021年6月24日上午09:32）</b></i></blockquote></p><p> Eli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p><p><blockquote>礼来公司(Eli Lilly)表示，其阿尔茨海默氏症治疗药物已获得美国食品和药物管理局的突破性疗法认定，该公司股价在早盘交易中上涨超过8%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p><p><blockquote></blockquote></p><p> The move is meant to expedite the development and review of the experimental treatment.</p><p><blockquote>此举旨在加快实验性治疗的开发和审查。</blockquote></p><p> Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p><p><blockquote>竞争对手百健(Biogen)的自有药物本月早些时候获得批准，该公司在盘前交易中股价下跌超过6%。FDA因批准该药物而面临一些医生和科学家的批评。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval<blockquote>礼来公司(Eli Lilly)股价上涨，百健(Biogen)因阿尔茨海默病治疗获得批准而下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval<blockquote>礼来公司(Eli Lilly)股价上涨，百健(Biogen)因阿尔茨海默病治疗获得批准而下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-06-24 19:48</span>\n</p>\n</h4>\n</header>\n<article>\n<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p><p><blockquote><i><b>（更新：美国东部时间2021年6月24日上午09:32）</b></i></blockquote></p><p> Eli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p><p><blockquote>礼来公司(Eli Lilly)表示，其阿尔茨海默氏症治疗药物已获得美国食品和药物管理局的突破性疗法认定，该公司股价在早盘交易中上涨超过8%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p><p><blockquote></blockquote></p><p> The move is meant to expedite the development and review of the experimental treatment.</p><p><blockquote>此举旨在加快实验性治疗的开发和审查。</blockquote></p><p> Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p><p><blockquote>竞争对手百健(Biogen)的自有药物本月早些时候获得批准，该公司在盘前交易中股价下跌超过6%。FDA因批准该药物而面临一些医生和科学家的批评。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1,"symbols_score_info":{"LLY":0.9}},"isVote":1,"tweetType":1,"viewCount":1717,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/126011346"}
精彩评论